FindTrial
Sign In

Why Treatment Delays Matter in Colorectal Cancer?

Delay in Colorectal Cancer Management and its Impact on Clinical Outcomes: A Retrospective Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091604
Enrollment
424
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K639- Disease of intestine, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

NGSM Institute of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years and more and primarily diagnosed with colorectal cancer. Patients treated with chemotherapy (with or without radiotherapy)

Exclusion criteria

Exclusion criteria: Patients with metastatic tumors originating from other primary sites. Patients treated only with radiotherapy.

Design outcomes

Primary

MeasureTime frame
To quantify the extent of diagnostic and treatment delays in colorectal cancerTimepoint: 8 months—

Secondary

MeasureTime frame
Identify the key factors contributing to these delays and its effect on clinical outcomes, including survival, disease progression/recurrenceTimepoint: 8 months—

Countries

India

Contacts

Public ContactDr Uday Venkat Mateti

NGSM Institute of Pharmaceutical Sciences

udayv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026